English
简体中文
Total: £ 56.28
Published Date: 2025-12-22 | Pages: 80 | Tables: 87 | Pharma & Healthcare
The global market for Pneumococcal Polysaccharide Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pneumococcal Polysaccharide Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pneumococcal Polysaccharide Vaccine include Merck & Co., Pfizer, Sanofi Pasteur, Walvax, Sinovac, Sino Biopharm, Kangtai Bio, Zhifei Biological, AIM Bio, Antejin Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pneumococcal Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Polysaccharide Vaccine.
The Pneumococcal Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pneumococcal Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pneumococcal Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck & Co.
Pfizer
Sanofi Pasteur
Walvax
Sinovac
Sino Biopharm
Kangtai Bio
Zhifei Biological
AIM Bio
Antejin Biotechnology
Segment by Type
PCV13
PPSV23
Others
Segment by Application
Hospital
Centers for Disease Control and Prevention
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pneumococcal Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Pneumococcal Polysaccharide Vaccine Market Overview
1.1 Product Definition
1.2 Pneumococcal Polysaccharide Vaccine by Type
1.2.1 Global Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 PCV13
1.2.3 PPSV23
1.2.4 Others
1.3 Pneumococcal Polysaccharide Vaccine by Application
1.3.1 Global Pneumococcal Polysaccharide Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Centers for Disease Control and Prevention
1.3.4 Others
1.4 Global Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pneumococcal Polysaccharide Vaccine Revenue 2020-2031
1.4.2 Global Pneumococcal Polysaccharide Vaccine Sales 2020-2031
1.4.3 Global Pneumococcal Polysaccharide Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pneumococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pneumococcal Polysaccharide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Date of Enter into This Industry
2.8 Global Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.8.1 Global Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue
2.8.3 Global Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pneumococcal Polysaccharide Vaccine Market Scenario by Region
3.1 Global Pneumococcal Polysaccharide Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2020-2031
3.2.1 Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2020-2025
3.2.2 Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2026-2031
3.3 Global Pneumococcal Polysaccharide Vaccine Revenue by Region: 2020-2031
3.3.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Region: 2020-2025
3.3.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Region: 2026-2031
3.4 North America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 North America Pneumococcal Polysaccharide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2031)
3.4.3 North America Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.5.1 Europe Pneumococcal Polysaccharide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2031)
3.5.3 Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Pneumococcal Polysaccharide Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pneumococcal Polysaccharide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pneumococcal Polysaccharide Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2031)
4.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2025)
4.1.2 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2026-2031)
4.1.3 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2020-2031)
4.2.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2020-2025)
4.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2026-2031)
4.2.3 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Pneumococcal Polysaccharide Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2031)
5.1.1 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2020-2025)
5.1.2 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2026-2031)
5.1.3 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2020-2031)
5.2.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2020-2025)
5.2.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2026-2031)
5.2.3 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Pneumococcal Polysaccharide Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck & Co.
6.1.1 Merck & Co. Company Information
6.1.2 Merck & Co. Description and Business Overview
6.1.3 Merck & Co. Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck & Co. Pneumococcal Polysaccharide Vaccine Product Portfolio
6.1.5 Merck & Co. Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Pneumococcal Polysaccharide Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Company Information
6.3.2 Sanofi Pasteur Description and Business Overview
6.3.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolio
6.3.5 Sanofi Pasteur Recent Developments/Updates
6.4 Walvax
6.4.1 Walvax Company Information
6.4.2 Walvax Description and Business Overview
6.4.3 Walvax Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Walvax Pneumococcal Polysaccharide Vaccine Product Portfolio
6.4.5 Walvax Recent Developments/Updates
6.5 Sinovac
6.5.1 Sinovac Company Information
6.5.2 Sinovac Description and Business Overview
6.5.3 Sinovac Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sinovac Pneumococcal Polysaccharide Vaccine Product Portfolio
6.5.5 Sinovac Recent Developments/Updates
6.6 Sino Biopharm
6.6.1 Sino Biopharm Company Information
6.6.2 Sino Biopharm Description and Business Overview
6.6.3 Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sino Biopharm Pneumococcal Polysaccharide Vaccine Product Portfolio
6.6.5 Sino Biopharm Recent Developments/Updates
6.7 Kangtai Bio
6.7.1 Kangtai Bio Company Information
6.7.2 Kangtai Bio Description and Business Overview
6.7.3 Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Kangtai Bio Pneumococcal Polysaccharide Vaccine Product Portfolio
6.7.5 Kangtai Bio Recent Developments/Updates
6.8 Zhifei Biological
6.8.1 Zhifei Biological Company Information
6.8.2 Zhifei Biological Description and Business Overview
6.8.3 Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Zhifei Biological Pneumococcal Polysaccharide Vaccine Product Portfolio
6.8.5 Zhifei Biological Recent Developments/Updates
6.9 AIM Bio
6.9.1 AIM Bio Company Information
6.9.2 AIM Bio Description and Business Overview
6.9.3 AIM Bio Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AIM Bio Pneumococcal Polysaccharide Vaccine Product Portfolio
6.9.5 AIM Bio Recent Developments/Updates
6.10 Antejin Biotechnology
6.10.1 Antejin Biotechnology Company Information
6.10.2 Antejin Biotechnology Description and Business Overview
6.10.3 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product Portfolio
6.10.5 Antejin Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pneumococcal Polysaccharide Vaccine Industry Chain Analysis
7.2 Pneumococcal Polysaccharide Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pneumococcal Polysaccharide Vaccine Production Mode & Process Analysis
7.4 Pneumococcal Polysaccharide Vaccine Sales and Marketing
7.4.1 Pneumococcal Polysaccharide Vaccine Sales Channels
7.4.2 Pneumococcal Polysaccharide Vaccine Distributors
7.5 Pneumococcal Polysaccharide Vaccine Customer Analysis
8 Pneumococcal Polysaccharide Vaccine Market Dynamics
8.1 Pneumococcal Polysaccharide Vaccine Industry Trends
8.2 Pneumococcal Polysaccharide Vaccine Market Drivers
8.3 Pneumococcal Polysaccharide Vaccine Market Challenges
8.4 Pneumococcal Polysaccharide Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Pneumococcal Polysaccharide Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Pneumococcal Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) of Key Manufacturers (2020-2025)
Table 5. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Pneumococcal Polysaccharide Vaccine Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Pneumococcal Polysaccharide Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Pneumococcal Polysaccharide Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Polysaccharide Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (Dose)
Table 18. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Pneumococcal Polysaccharide Vaccine Sales by Region (2026-2031) & (Dose)
Table 20. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Pneumococcal Polysaccharide Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Pneumococcal Polysaccharide Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Pneumococcal Polysaccharide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (Dose)
Table 27. North America Pneumococcal Polysaccharide Vaccine Sales by Country (2026-2031) & (Dose)
Table 28. North America Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Pneumococcal Polysaccharide Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (Dose)
Table 32. Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2026-2031) & (Dose)
Table 33. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Pneumococcal Polysaccharide Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (2020-2025) & (Dose)
Table 37. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Region (2026-2031) & (Dose)
Table 38. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (Dose)
Table 42. Latin America Pneumococcal Polysaccharide Vaccine Sales by Country (2026-2031) & (Dose)
Table 43. Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pneumococcal Polysaccharide Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2020-2025) & (Dose)
Table 47. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2026-2031) & (Dose)
Table 48. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Type (2020-2025)
Table 51. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Type (2026-2031)
Table 52. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2020-2025)
Table 59. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2026-2031)
Table 60. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Application (2020-2025)
Table 61. Global Pneumococcal Polysaccharide Vaccine Sales (Dose) by Application (2026-2031)
Table 62. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2020-2025)
Table 69. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2026-2031)
Table 70. Merck & Co. Company Information
Table 71. Merck & Co. Description and Business Overview
Table 72. Merck & Co. Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. Merck & Co. Pneumococcal Polysaccharide Vaccine Product
Table 74. Merck & Co. Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Pfizer Pneumococcal Polysaccharide Vaccine Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Sanofi Pasteur Company Information
Table 81. Sanofi Pasteur Description and Business Overview
Table 82. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product
Table 84. Sanofi Pasteur Recent Developments/Updates
Table 85. Walvax Company Information
Table 86. Walvax Description and Business Overview
Table 87. Walvax Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Walvax Pneumococcal Polysaccharide Vaccine Product
Table 89. Walvax Recent Developments/Updates
Table 90. Sinovac Company Information
Table 91. Sinovac Description and Business Overview
Table 92. Sinovac Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Sinovac Pneumococcal Polysaccharide Vaccine Product
Table 94. Sinovac Recent Developments/Updates
Table 95. Sino Biopharm Company Information
Table 96. Sino Biopharm Description and Business Overview
Table 97. Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. Sino Biopharm Pneumococcal Polysaccharide Vaccine Product
Table 99. Sino Biopharm Recent Developments/Updates
Table 100. Kangtai Bio Company Information
Table 101. Kangtai Bio Description and Business Overview
Table 102. Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. Kangtai Bio Pneumococcal Polysaccharide Vaccine Product
Table 104. Kangtai Bio Recent Developments/Updates
Table 105. Zhifei Biological Company Information
Table 106. Zhifei Biological Description and Business Overview
Table 107. Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Zhifei Biological Pneumococcal Polysaccharide Vaccine Product
Table 109. Zhifei Biological Recent Developments/Updates
Table 110. AIM Bio Company Information
Table 111. AIM Bio Description and Business Overview
Table 112. AIM Bio Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. AIM Bio Pneumococcal Polysaccharide Vaccine Product
Table 114. AIM Bio Recent Developments/Updates
Table 115. Antejin Biotechnology Company Information
Table 116. Antejin Biotechnology Description and Business Overview
Table 117. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product
Table 119. Antejin Biotechnology Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Pneumococcal Polysaccharide Vaccine Distributors List
Table 123. Pneumococcal Polysaccharide Vaccine Customers List
Table 124. Pneumococcal Polysaccharide Vaccine Market Trends
Table 125. Pneumococcal Polysaccharide Vaccine Market Drivers
Table 126. Pneumococcal Polysaccharide Vaccine Market Challenges
Table 127. Pneumococcal Polysaccharide Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pneumococcal Polysaccharide Vaccine
Figure 2. Global Pneumococcal Polysaccharide Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pneumococcal Polysaccharide Vaccine Market Share by Type: 2024 & 2031
Figure 4. PCV13 Product Picture
Figure 5. PPSV23 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Pneumococcal Polysaccharide Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Pneumococcal Polysaccharide Vaccine Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Centers for Disease Control and Prevention
Figure 11. Others
Figure 12. Global Pneumococcal Polysaccharide Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Pneumococcal Polysaccharide Vaccine Market Size (2020-2031) & (US$ Million)
Figure 14. Global Pneumococcal Polysaccharide Vaccine Sales (2020-2031) & (Dose)
Figure 15. Global Pneumococcal Polysaccharide Vaccine Average Price (US$/Dose) & (2020-2031)
Figure 16. Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 17. Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2024
Figure 18. Global Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Pneumococcal Polysaccharide Vaccine Players: Market Share by Revenue in Pneumococcal Polysaccharide Vaccine in 2024
Figure 20. Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Pneumococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2020-2031)
Figure 23. North America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2020-2031)
Figure 24. United States Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2020-2031)
Figure 27. Europe Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2020-2031)
Figure 28. Germany Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2020-2031)
Figure 35. China Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Colombia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Pneumococcal Polysaccharide Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Pneumococcal Polysaccharide Vaccine by Type (2020-2031)
Figure 54. Global Revenue Market Share of Pneumococcal Polysaccharide Vaccine by Type (2020-2031)
Figure 55. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Type (2020-2031)
Figure 56. Global Sales Market Share of Pneumococcal Polysaccharide Vaccine by Application (2020-2031)
Figure 57. Global Revenue Market Share of Pneumococcal Polysaccharide Vaccine by Application (2020-2031)
Figure 58. Global Pneumococcal Polysaccharide Vaccine Price (US$/Dose) by Application (2020-2031)
Figure 59. Pneumococcal Polysaccharide Vaccine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
